Skip to main content
. 2022 May 27;8(6):576. doi: 10.3390/jof8060576

Table 1.

Main comparative data of Aspergillus inpatients in Spain during 1997–2017: Deaths vs. Survivors.

TOTAL, n (%)
N = 32,960 Cases (100%)
Deaths, n (%)
N1 = 8080 (24.5%)
Survivors, n (%)
N2 = 24,880 Cases (75.5%)
p-Value OR (95% CI)
Age, mean ± SD 61.1 ± 19.1 64.1 ± 17.2 60.2 ± 19.6 <0.001
<15 years 1009 (3.1) 154 (1.9) 855 (3.4) <0.001 *
15–44 years 4753 (14.4) 861 (10.7) 3892 (15.6)
45–64 years 9921 (30.1) 2331 (28.8) 7590 (30.5)
65–74 years 8437 (25.6) 2237 (27.7) 6200 (24.9)
≥75 years 8840 (26.8) 2497 (30.9) 6343 (25.5)
Gender
Male 22,383 (67.9) 5739 (71.0) 16,643 (66.9) <0.001 * 1.2 (1.1–1.3)
Female 10,577 (32.1) 2341 (29.0) 8236 (33.1)
Diagnosis causing hospitalization
Principal diagnosis 6574 (19.9) 1496 (18.5) 5078 (20.4) <0.001 * 1.1 (1.0–1.2)
Secondary diagnosis 26,386 (80.1) 6584 (81.5) 19,802 (79.6)
Process type
Medical 21,728 (65.9) 4724 (58.5) 17,004 (68.3) <0.001 * 0.6 (0.6–0.7)
Surgical 4474 (13.6) 1368 (16.9) 3105 (12.5)
Unclassified 6758 (20.5) 1987 (24.6) 4771 (19.2)
Hospital stays (days), mean ± SD 26.8 ± 26.9 32.2 ± 29.4 25.0± 25.8 <0.001 **

* Pearson’s χ2 Test; ** ANOVA; p < 0.05 (statistically significant).